Provided is a compound of formula (I):
or a pharmaceutically acceptable salt thereof. Also provided is a method of activating the Nrf2 pathway, comprising contacting cells with a sufficient amount of a compound of formula (I) described herein. Also provided is a method of treating a neurodegenerative disease, comprising administering to a subject in need of treatment for the neurodegenerative disease an effective amount of a compound of formula (I) described herein.
Single‐Site Molybdenum Catalyst for the Synthesis of Fumarate
作者:Huifang Jiang、Rui Lu、Xiaoqin Si、Xiaolin Luo、Jie Xu、Fang Lu
DOI:10.1002/cctc.201900332
日期:2019.9.5
pyridine nitrogen and oxygen in hydroxyl of 8‐hydroxyquinoline coordinated with Mo atom. The crystal catalyst was stabilized by π‐π stacking interaction and hydrogen bonds to form isolated Mo specie. The single‐site molybdenumcatalyst exhibited excellent catalytic performance in didehydroxylation reactions with highselectively of dibutyl fumarate (86 %) product at mild reaction condition. Deuterium isotopic